Myasthenia gravis during interferon alfa therapy.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 7854543.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients treated with interferon alfa can develop autoantibodies and autoimmune diseases. We describe two patients who developed myasthenia gravis with abnormal levels of serum anti-acetylcholine receptor antibodies during interferon alfa-2b treatment for malignancies. One of these patients had myopathic findings on EMG and focal deficiency of cytochrome c oxidase on muscle biopsy.
Medical subject headings
- Interferon-alpha
- Lymphoma, Non-Hodgkin
- Myasthenia Gravis
- Urinary Bladder Neoplasms